CEO, TargEDys, France
The two-day meeting hosted numerous presentations on probiotics discovery and product development, as well as prebiotics, diet and nutrition. Alongside a number of case studies on digestive health, metabolic diseases, ageing, skin health and allergy, the conference highlighted the developments in personalised nutrition and explored strategies for commercialisation. The FDA had been invited to speak on the regulatory aspects of probiotic products.
The meeting was once again collocated with the 8th Microbiome R&D and Business Collaboration Forum: USA and 2nd Skin & Cosmeceuticals Congress: USA. Attendees could track-hop between all three events and have access to 100 presentations.
A panel discussion explored the various sources of funding for microbiome products. Expert-led round tables provided delegates with a forum to discuss a range of topics such as the challenges for microbiome-based precision medicine or the skin microbiome and the future of “clean beauty.”
“there was a wide spectrum of presentations for Microbiome area, high level of presenters, especially in Bioinformatics and Computational biology”
“I got to learn about up-to-date research and product development”
“great structure, liked all the talks running in parallel”
Assistant Professor, Department of Molecular Biology & Biochemistry University of California, Irvine
This programme is designed to create a collaborative environment in which delegates could enduring relationships across the full range of microbiome and probiotics research.
The agenda in brief
What you will get